MENTORS
Alphabetically sorted by last name.
[av_one_third first

Che-Chang Chang, Associate Professor
The Ph.D. Program for Translational Medicine, College of Medical Science and Technology
Office of Global EngagementMentor profile
Education
2005-2012 Postdoc fellow, Institute of Biomedical Sciences
Academia Sinica, Taiwan
Ph.D., The Graduate Institute of Life Sciences(GILS)
National Defense University, Taiwan
M.S. in Biology
B.S. in Biology
Fu Jen Catholic University, Taiwan
Professional Appointments
2024- Professor, The Ph.D. Program for Translational Medicine
2020- Associate Professor, International Ph.D. Program for Translational Science
Taipei Medical University, Taiwan
Introduction
Dr. Che-Chang Chang is an expert in cancer biology and translational medicine.
Dr. Che-Chang Chang’s Lab is focus on the cancer research and therapy. We use genomic and proteomics strategies to identify the cancer biomarkers and potential therapeutic targets. In addition, we perform the cellular functional assays, molecular experiments and PDOX mouse model for validation. Our goal is use translational medicine to bridge the bedside clinical question and bench basic research.
Research interests
- Post-translational modification
- Signal transduction in cancer
- Gene transcriptional regulation
- Molecular cell biology
Requirements and details
Scholarship availability
Taiwan Experience Education Program, TEEP (MOE) | |
International Internship Pilot Program, IIPP (NSTC) | More info |

Ching-Wen Chang, Assistant Professor
Graduate Institute of Metabolism and Obesity Sciences, College of Nutrition
Office of Global EngagementMentor profile
Education
Ph.D. in Oral biology
M.S. in Oral biology
National Yang-Ming University
B.S. in Food Science
National Ilan University
Professional Appointments
2023- Assistant Professor, Graduate Institute of Metabolism and
Obesity Sciences
Taipei Medical University, Taiwan
2019-2022 Postdoctoral Fellow (CRTA), National Cancer Institute
National Institutes of Health, USA
Introduction
I am Dr. Ching-Wen Chang, honored to hold the position of Assistant Professor at the esteemed Graduate Institute of Metabolism and Obesity Sciences, Taipei Medical University. My specialization lies in intricate molecular research, primarily aimed at unveiling innovative molecular avenues to categorize tumor subtypes and unearth biomarkers crucial for early detection, accurate diagnosis, prognosis discernment, and prediction in liver diseases, including liver cancer and Nonalcoholic steatohepatitis (NASH).
Research Focus:
My pursuit in research is driven by a profound aspiration to decode the complex molecular mechanisms underlying liver diseases. By delving deep into the molecular intricacies of liver pathology, I aim to propel advancements in precision medicine, focusing on liver cancer and NASH. This endeavor is pivotal to enriching our understanding and management of liver conditions and contributing meaningful insights to the broader scientific community.
Mentorship Philosophy:
In my role as a mentor and educator, I strive to nurture and enlighten the upcoming generation of scientists by providing guidance in both wet-lab methodologies and computational biology. Leveraging my extensive research experience and knowledge, my goal is to create a conducive and enriching learning atmosphere, fostering curiosity, analytical thinking, and a profound passion for molecular research amongst my students.
Commitment to Excellence:
I derive immense satisfaction and fulfillment from imparting knowledge and wisdom, with the hope of sparking an enduring passion for discovery and research in the promising minds of the future. My unwavering commitment is to uphold and promote academic and research excellence. I hold a steadfast hope to witness my mentees unfold novel perspectives and contribute groundbreaking revelations to our cumulative knowledge of liver diseases and their molecular foundations, ultimately benefiting the global scientific realm.
The laboratory I oversee, situated within the Graduate Institute of Metabolism and Obesity Sciences, operates at the forefront of innovative research focusing on metabolism, obesity, and liver maladies, encompassing hepatocellular carcinoma and Nonalcoholic steatohepatitis (NASH). Our research environment is a nexus of relentless curiosity, pursuit of profound understanding, and a dedication to trailblazing methodologies in molecular studies.
Our ambition is to make substantial contributions to multiple scientific domains, including early detection, meticulous diagnosis, informed prognosis, and the cultivation of precise medical strategies. Our objectives are harmoniously aligned with the mission to decipher and provide new insights into the intricate molecular mechanisms underlying liver diseases.
Research interests
- Identification and Characterization of Nonalcoholic Steatohepatitis
- Underlying Mechanisms of Metabolic Reprogramming in Liver Disease
- Big Data Analytics
- Understanding the Intersections between Metabolism and Cancer Biology
- Establishing Animal Models for Hepatocellular Carcinoma
Requirements and details
Scholarship availability
Taiwan Experience Education Program, TEEP (MOE) | |
International Internship Pilot Program, IIPP (NSTC) | More info |

Shu-Chun Chang, Associate Professor
The Ph.D. Program for Translational Medicine, College of Medical Science and Technology
Office of Global EngagementMentor profile
Education
2011~2015 PostDoc Research Fellow, Department of Biological Sciences
National University of Singapore, Singapore
Ph.D., Division of National Heart & Lung Institute, Faculty of Medicine
Imperial College London, UK
Professional Appointments
2022- Associate Professor, Graduate Institute of Biomedical Informatics
2017-2022 Assistant Professor, Graduate Institute of Biomedical Informatics
2015-2017 Assistant Professor, Ph.D. Program for Translational Medicine
Taipei Medical University, Taiwan
Introduction
Shu-Chun Chang is an Associate Professor of the Ph.D. Program for Translational Medicine, Taipei Medical University, Taiwan. Dr. Chang trained in extracellular biology and glycobiology and began work on cancer research as her PhD study in Imperial College London (IC, 2007-2011). Her PhD work aimed to investigate the role of Hedgehog Acyltransferase & Heparan Sulphate Proteoglycans (HSPGs) in Human Sonic Hedgehog (hShh) Signaling. These studies have greatly contributed to defining the functional roles of hShh interactions with HSPGs and palmitoylation of hShh in the formation of hShh multimeric complex, which enabled cancer cell therapeutics. Dr Chang continued to work in the field of Cancer Immunology/Inflammation as her Post-Doc research at the National University of Singapore (NUS, 2011-2015). Her findings clearly established the power of SAG-UPS (ubiquitin proteasome system) as a functional link between immune defense and apoptosis or immune-overactivation and tumorigenesis. SAG–UPS was proposed to be an efficient target for developing therapeutics against autoimmune diseases and cancers. Continuing from her postdoctoral research work, her current independent research focusses on: UPS, E2/E3 enzymes profiling, cancer therapeutics and anticancer strategies, the tumorigenic microenvironment, Hiltonol cocktails in anti-cancer strategies, anti-PD-L1 cancer vaccine. All of these related topics of research encompasses cancer immunomodulation, which she is being recognized internationally, as evidenced by multiple invitations from impactful journals to her to submit manuscripts to contribute her area of expertise.
Previously, Dr Chang revealed that dysregulation of the ubiquitination-proteasome system (UPS) exacerbates the tumor microenvironment and drives malignant transformation [1-3]. As the largest family of E3 ligases, the SCF E3 is involved in chronic inflammation-mediated tumorigenesis such as BRCA [4,5]. However, the underlying mechanisms and key factors through which SCF E3 ligase drives BRCA initiation and progression remain unclear. During Dr Chang’s research period in TMU (2015-current), since her research encompasses a wide array of experimental approaches (e.g. biochemical, cell & molecular techniques, molecular biophysics, computational modeling and immunochemical methods involving clinical specimens), as a Principle Investigator, Dr Chang has put together a team of collaborators and co-workers (both locally at TMU and internationally) to derive the best output and to spawn research collegiality and inculcate team-spirit. In the future, Dr Chang aim to investigate potent approaches to restrain the pro-tumorigenic microenvironment to inhibit cancer cell growth and metastasis.
Research interests
- BZDRs promote breast cancer progression through GABRA3-ECM signaling.
- Clarify PBMCs-associated tumorigenic microenvironment mediated by Musa Sapientum extracts.
Requirements and details
Scholarship availability
Taiwan Experience Education Program, TEEP (MOE) | |
International Internship Pilot Program, IIPP (NSTC) | More info |

Susan Jung-Su Chang, Professor
Graduate Institute of Metabolism and Obesity Sciences, College of Nutrition
Office of Global EngagementMentor profile
Education
Ph.D., Center For Infectious Disease
University College London, UK
M.S., in Human Nutrition
Glasgow University, UK
B.S., Department of food Science and Technology
Chia Nan University, Taiwan
Professional Appointments
2019- Professor, School of Nutrition and Health Sciences
2018- Professor, Graduate Institute of Metabolism and Obesity Sciences
Taipei Medical University, Taiwan
Introduction
Prof. Jung-Su Chang was awarded her Master’s degree in Clinical Nutrition from the University of Glasgow in 2000 and her PhD degree from University College London (UCL), UK, in 2006. She obtained her postdoctoral training in Prof. David Haig’s Lab at the Moredun Research Institute and the Roslin Research Institute in Scotland, as well as in Prof. Dirk Haller’s Lab at the Technical University Munich, Germany. In 2011, she joined the School of Nutrition & Health Sciences at Taipei Medical University, Taiwan.
Prof. Chang has dedicated her research to obesity-related nutrition care. Obesity and anemia remain major global health concerns. It is estimated that half of obese patients with metabolic disorders have mild liver iron overload, but there are still no effective methods for treating obesity-related iron disorders.
Prof. Chang is intrigued by questions: How does obesity-related inflammation affect iron metabolism, and how does altered iron metabolism contribute to metabolic diseases and brain health? Can digital technology and artificial intelligence (AI) help us provide better nutrition care?
Currently, Prof. Jung-Su Chang’s lab consists of one postdoctoral researcher and two PhD students (one from Vietnam and one from Indonesia), along with four Taiwanese master’s students .
Research interests
- Iron metabolism
- Metabolic syndrome
- Dietary pattern and disease risk
- Inflammation and infection
Requirements and details
- Undergraduate or above
- Familiar with excel, basic statistics, and can use Graphapad prism, spss , or R and SAS
- Wet Lab project skills
- Familiar with Large Language Model, machine learning
Scholarship availability
Taiwan Experience Education Program, TEEP (MOE) | |
International Internship Pilot Program, IIPP (NSTC) | More info |

Jane C-J Chao
School of Nutrition and Health Sciences
Office of Global EngagementMentor profile
Education
Ph.D., Department of Human Nutrition and Food Management
M.S., Department of Food Science and Nutrition
The Ohio State University, USA
B.S., School of Nutrition and Health Sciences
Taipei Medical University, Taiwan
Professional Appointments
2024.02- Dean, Office of Global Engagement
2015.08- Adjunct Professor, School of Health Care Administration
2004.02- Professor, School of Nutrition and Health Sciences
Taipei Medical University, Taiwan
Introduction
Dr. Jane C.-J. Chao graduated from the Department of Human Nutrition and Food Management at The Ohio State University and obtained her Ph.D. degree in 1993. Subsequently, she received post-doctoral training in the Division of Foods and Nutrition at the University of Illinois at Urbana-Champaign from 1993 to 1994. She then returned to her alma mater Taipei Medical University to be a faculty member in the School of Nutrition and Health Sciences since 1995. She is currently the Dean of the Office of Global Engagement and a professor in the School of Nutrition and Health Sciences at Taipei Medical University. Over the past 30 years, her research primarily focuses on the effects of herbal extracts and active components on gastrointestinal diseases. She published numerous SCI journal papers and several book chapters, served as a reviewer for journals, and worked as a guest professor at the Health Sciences University of Hokkaido. She is currently a member of the American Society for Nutrition, the President of the Nutrition Society of Taiwan, and the Executive supervisor of the Chinese Taipei Association for the Study of Obesity. She has devoted herself to innovative research in herbal foods and gastrointestinal diseases continuously.
Lab 657 in the School of Nutrition and Health Sciences at Taipei Medical University (TMU) is a molecular nutrition laboratory. We currently have 15 lab members including 1 PI (me), 2 research assistants, 1 postdoc (from Malaysia), 4 doctoral students (2 from Vietnam), 3 master’s students (1 from Vietnam), and 4 professional master’s students. Among 15 lab members, there are 4 foreigners. The research in our lab mainly focuses on the effects of Lycium barbarum polysaccharides, probiotics, and postbiotics on the progression and remission of ulcerative colitis using animal and cell models with the collaboration of Prof. Tomonori Nochi at Tohoku University in Japan. Additionally, we are interested in the evaluation of functional foods on chronic diseases using animal or human studies. We have collaborated with Prof. Chyi-Huey Bai in the School of Public Health at TMU and Prof. Chien-Yeh Hsu at the National Taipei University of Nursing and Health Sciences to determine the association between dietary patterns and chronic diseases using big data analysis.
Research interests
- Applications of plant extracts/active components such as Lycium barbarum polysaccharides extract and probiotics to health foods and adjunctive therapy for chronic diseases (IBD, sarcopenia, ulcer, stroke, or hepatitis) and cancers (cell, animal, or human study)
- Precise prediction model of the recovery in hip fracture patients after surgery (human study)
- Evaluation of functional foods (animal or human study)
- Association between dietary patterns and chronic diseases (data analysis)
Requirements and details
Senior undergraduate or graduate students with a background in nutrition, medicine, or life science-related fields.
Scholarship availability
Taiwan Experience Education Program, TEEP (MOE) | |
International Internship Pilot Program, IIPP (NSTC) | More info |

Hsin-Yi Chen, Associate Professor
Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology
Office of Global EngagementMentor profile
Education
Ph.D., Institute of Molecular Medicine
Master, Institute of Medical Technology
BS. in Medical Technology
National Taiwan University, Taiwan
Professional Appointments
2021- Associate Professor, Ph.D Program for Cancer Molecular Biology and Drug Discovery
2021- Associate Professor, Graduate Institute of Cancer Biology and Drug Discovery
Taipei Medical University, Taiwan
Introduction
During my postdoc training, I focused on the functions of noncoding RNAs in cancer development. Our work “miR-103/107 promote metastasis of colorectal cancer by targeting the metastasis suppressors DAPK and KLF4.” has been published in 2012 and got 333 citations (Chen et al., Cancer Res. 72:3631-41, 2012.). In 2014, I joined TMU and extended my research to long non-coding RNAs. We used bioinformatic tools to identified some lncRNAs that could contribute to tumor progression and delineate their molecular mechanism by multiple molecular, cellular and in vivo approaches. In 2022, we identified “a novel lncRNA Smyca which coactivates TGF-β/Smad and Myc pathways to drive tumor progression” (Chen et al., J Hematol Oncol. 15:85, 2022.). In this work, we collaborated with Dr. Becky Chen in National Tsing Hua University to develop the “nanoparticle-assisted gapmer antisense oligonucleotides delivery” to target Smyca in vivo. Our result suggests targeting Smyca prevents metastasis and overcomes chemoresistance, therefore provide the preclinical evidence for therapeutic insight of Smyca.
Currently, my lab focuses on three aspects. First, we extend our work on Smyca to dig other therapeutic application. Second, we investigate the roles of interested lncRNAs in tumor progression and their impact on tumor microenvironment. Third, we collaborate with drug delivery team to refine the strategy for lncRNA targeting.
Research interests
- Tumor biology
- MicroRNA
- Protein turnover
- Signal transduction
Requirements and details
-
BSc / MSc / PhD in life and biomedical sciences, molecular biology, or biology-related fields.
-
Skill sets or Qualities
- Cell culture
- Knowledge and skills of biochemical analysis for DNA/RNA/Protein
- Knowledge and skills of cell biology
- Effective communication skills in English
- Teamwork mindset
Scholarship availability
Taiwan Experience Education Program, TEEP (MOE) | |
International Internship Pilot Program, IIPP (NSTC) | More info |
hyichen@tmu.edu.tw

Tuo-Yu Chen, Assistant Professor
Global Health and Health Security, College of Public Health
Office of Global EngagementMentor profile
Education
Ph.D., School of Aging Study
University of South Florida, USA
M.S. in Occupational Therapy
University of Pittsburgh, USA
B.S. in Occupational Therapy
Chung Shan Medical University, Taiwan
Professional Appointments
2020- Assistant Professor, Master Program in Global Health and Development
Taipei Medical University, Taiwan
2019-2020 Postdoctoral Fellow
Nanyang Technological University, Singapore
2017.05-2017.06 Visiting Research Fellow, Population Research Institute
Nihon University, Japan
Introduction
Tim is an occupational therapist by training. He received his Ph.D. in Aging Studies from the University of South Florida. The overarching theme of his research is the promotion of healthy aging. The broad focus of his research program is to 1) identify physical and psychosocial determinants of health outcomes and 2) examine potential interventions to reduce the likelihood of developing aging-related health problems. He studies various physical and mental health outcomes, including but not limited to sleep, depression, pain, fear of falling, falls, impaired mobility, and chronic conditions. His recent research centers on promoting sleep health in the older population.
The Aging and HeAlth Lab – the AHA lab
Research interests
- Sleep health
- Geriatric syndromes (e.g., falls, pain, frailty, depression)
- Disability in late life
- Aging and health disparity
- Cross-country comparisons on aging and health
Requirements and details
Scholarship availability
Taiwan Experience Education Program, TEEP (MOE) | |
International Internship Pilot Program, IIPP (NSTC) | More info |

Yi-Fan Chen, Associate Professor
International Master Program for Translational Science, College of Medical Science and Technology
Office of Global EngagementMentor profile
Education
Ph.D. Life Sciences and Institute of Genome Sciences
National Yang-Ming University, Taiwan
M.S. Institute of Microbiology and Immunology
National Defense Medical Center, Taiwan
B.S. Department of Medical Laboratory Science and Biotechnology
China Medical University, Taiwan
Professional Appointments
2020- Associate Professor, Ph.D. Program for Translational Medicine
2020- Associate Professor, Graduate Institute of Biomedical Informatics
2020- Associate Professor, Master Program in Clinical Pharmacogenomics and Pharmacoproteomics
Taipei Medical University, Taiwan
Introduction
Dr. Yi-Fan Chen is an associate professor in Taipei Medical University. Dr. Chen possesses expertise in the fields of Genetics, Geroscience & Geriatrics, and Genetically modified mouse models. When she was a PhD student at National Yang-Ming University, she dedicated herself to the study of aging research. Aging is a progressive functional decline, or a gradual deterioration of physiological function with age, including irreversible age-related process of loss of viability. Exploring a potential strategy to maintain and rejuvenate mitochondrial health is extremely important. She and her mentor, Prof. Ting-Fen Tsai, proposed that Cisd2, a gene with a critical function in modulating health span in mammals, contributes to maintain mitochondrial integrity and functions majorly. Based on this concept, when she started her career at Taipei Medical University, she proposed that an age-dependent decrease of Cisd2 in hair cells and/or auditory nerves leads to age-related hearing loss in mice. This auditory study is being processed for the final mechanism examination. Additionally, they demonstrated that Cisd2 can be a critical target for ameliorating the disease progression of Alzheimer’s disease by maintaining mitochondrial function and integrity .
In recent years, Dr. Chen has a strong passion for investigating stem cells and their surrounding microenvironment. She hypothesizes that controlling the cell fate and stemness of stem cells is highly necessary to prolong the health-span of tissues; otherwise, age-dependently accumulated waste and stress can paralyze the tissue functions. In her lab, they demonstrated that Rrm2b, a critical protein controlling mitochondrial functions, plays an important role in regulating the regeneration capacity of stem cells, resulting in tissue dysfunction and senescence. They pointed out the importance of Rrm2b in myofibers following the investigation of molecular mechanisms in myofiber (part of niche) to modulate the cell fate of muscle stem cells . She believes that establishing mouse models for investigating the relationship between diseases and risk factors is a critical contribution for developing the therapeutic methods. If everyone can follow the principles of 3R, undoubtedly, mouse model will contribute to being a perfect in vivo model.
Aging is a progressive functional decline, or a gradual deterioration of physiological function with age, including irreversible age-related process of loss of viability. In human, several aging-related diseases such as neurodegenerative, cardiovascular diseases, diabetes have endangered human life and affected the life quality. Mitochondria is the energy factory in cell and also play the key role in cellular metabolism. As we known, dysfunctional mitochondria are primary defects in most diseases, especially age associated diseases. To explore a potential strategy to maintain and rejuvenate mitochondrial health is extremely important.
Research interests
- Gerontology
- Mouse genetics
Requirements and details
Scholarship availability
Taiwan Experience Education Program, TEEP (MOE) | |
International Internship Pilot Program, IIPP (NSTC) | More info |

Kuei-Ru Chou, Professor
School of Nursing, College of Nursing
Office of Global EngagementMentor profile
Education
Ph.D. in Nursing
Vanderbilt University, USA
M.S. School of Nursing
B.S. School of Nursing
National Defense Medical Center, Taiwan
Professional Appointments
2023-present Fellows Ad Eundem of the Faculty of Nursing & Midwifery
Royal College of Surgeons in Ireland (FFNMRCSI), Ireland
2019-Present Fellows
American Academy of Nursing (FAAN), USA
2018-Present Distinguished Professor
Taipei Medical University, Taiwan
Introduction
Dr. Kuei-Ru Chou is a distinguished professor in the School of Nursing, College of Nursing at Taipei Medical University. She has made tremendous contributions to gerontology nursing in practice and evidence-based research working in both public and private institutions for 35 years.
(1) Dr. Chou has conducted research in nursing, gerontology, and mental health making global citizens become more aware of the importance of healthcare providers and the need for nursing research. Dr. Chou’s innovative and outstanding program of healthcare research has had a global reach generating knowledge that has improved the standard of living for patients and caregivers.
(3) Dr. Chou has actively promoted psychiatric home health care and made significant improvements in gerontological psychiatric health care, including the development of dementia care guidelines for older adults. Dr. Chou has also dedicated her efforts to enhancing the training of home healthcare staff as the supervisor of Taiwan’s Home Care and Services Association.
(4) Dr. Chou fostered collaborations with universities in over 48 countries ensuring the global exchange of knowledge and best practices in nursing during her tenure as the Dean of the College of Nursing. She continues to foster global connections as the Dean of the Office of Global Engagement and is currently the President of the Taiwan Sigma Theta Tau Chapter. Through her strong leadership and passionate advocacy, Dr. Chou’s organization has spearheaded the advancement of innovation, quality, and services in long-term care.
(5) Dr. Chou has invested considerable time and energy in mentoring students and new researchers, thus promoting a culture of research and innovation. Her guidance has impacted over 100 graduate students and hundreds of faculty members, leaving a lasting legacy in the nursing community.
Chou’s Lab is an inclusive and integrative lab focused on exploring cutting-edge cognitive training research for mild cognitive impairment and dementia, innovative swallowing function research for presbyphagia and dysphagia, effective and accessible cognitive-behavioral therapy research for patients and caregivers with mental health disorders, and evidence-based research for music and light Therapy.
(1) Cognitive Training Research for Mild Cognitive Impairment and Dementia
Dr. Chou is a pioneer of multi-domain cognitive training research that focuses on interactive cognitive function training and virtual interactive memory training programs which promote and extend the value and knowledge of nursing research. This research promotes and extends the value and knowledge of nursing research on domestic and international levels.
(2) Innovative Swallowing Function Research for Presbyphagia and Dysphagia
Dr. Chou’s dysphagia and dementia research focuses on developing innovative programs that combine different types of swallowing exercises and rehabilitation strategies to improve outcomes and standards of living for older adults and their caregivers.
(3) Cognitive-Behavioral Therapy Research for Patients and Caregivers with Mental Health Disorders
Dr. Chou’s mental health research ensures effective and accessible interventions including cognitive behavioral therapy for patients and caregivers with mental health disorders that improve mental health service access.
(4) Evidence-Based Research for Music and Light Therapy
Dr. Chou’s evidence-based research on music and light therapy provides a platform that facilitates other psychiatric hospitals to adopt music and light therapy as part of mental health care programs.
(5) Mentorship
Dr. Chou facilitates learning using multiple strategies that meet learners’ educational needs, model professional behavior, and stimulate critical thinking, and time management in the lab. Dr. Chou also facilitates learner development and socialization through recognition and adaptation of the unique learning styles of domestic and international masters and Ph.D. students and offers appropriate learner resources, advice, and counselling.
Research interests
- Mental Health Nursing
- Translational Research
- Long-term Care
- Cognitive Therapy
- Meta-Analysis
- Counselling
- Elderly Care
- Scale Development
Requirements and details
Scholarship availability
Taiwan Experience Education Program, TEEP (MOE) | |
International Internship Pilot Program, IIPP (NSTC) | More info |

Jian-Ying Chuang, Professor
International Master Program in Medical Neuroscience, College of Medical Science and Technology
Office of Global EngagementMentor profile
Education
Ph.D. in Molecular Biology
M.S. in Biomedical Sciences
National Cheng-Kung University, Taiwan
B.S. in Biology
Kaohsiung Medical University, Taiwan
Professional Appointments
2024.02-2024.03 Acting Director, Graduate Institute of Biomedical Informatics
2022- Professor, International Master Program in Medical Neuroscience
2021- Vice Dean, College of Medical Science and Technology
Taipei Medical University, Taiwan
Introduction
Increasing evidence suggests a link between dysregulation of histone deacetylases (HDACs) activity and many neoplastic/neurodegenerative diseases, as it regulates acetylation of multiple proteins and affects cellular functions, including cell growth, apoptosis, moving, etc. I have been focusing on HDAC research for thirteen years, including postdoctoral research at National Cheng Kung University (2010-2011), postdoctoral research at National Institute on Drug Abuse (2011-2013), and teaching at Taipei Medical University (2013-present). Interestingly, our lab recently discovered that HDACs have completely different functions in promoting cell survival like yin and yang regulation in different cells (Brain tumor cells and nerve cells), and these findings are supported by the following projects.
- To study the role of specificity protein 1 (Sp1) in cancer drug resistance (2016/08/01~2019/10/31), 105-2320-B-038-063 (1/3); 106-2320-B-038-002 (2/3); 107-2320-B-038-002 (3/3)
- Roles of HDAC6-mediated Sp1 deacetylation in the evolution of acquired temozolomide resistance in glioblastoma (2017/08/01~2019/07/31), 106-2320-B-038-028
- Investigating nerve regeneration following traumatic brain injury (2020/02/01~2025/01/31), 109-2636-B-038-002 (1/5), 110-2636-B-038-004 (2/5), 111-2636-B-038-006 (3/5), 112-2636-B-038-006 (4/5), 113-2636-B-038 001 (5/5)
Research interests
- Investigating nerve regeneration following traumatic brain injury
- Investigating the glioblastoma microenvironment and developing novel therapeutic strategies
Requirements and details
Scholarship availability
Taiwan Experience Education Program, TEEP (MOE) | |
International Internship Pilot Program, IIPP (NSTC) | More info |

Kai-Jen Chuang, Professor
Department of Public Health, School of Medicine, College of Medicine
Office of Global EngagementMentor profile
Education
Ph.D., Institute of Occupational Medicine and Industrial Hygiene
M.S., Institute of Occupational Medicine and Industrial Hygiene
National Taiwan University, Taiwan
Professional Appointments
2020.01- Professor, School of Public Health
2017.02- Professor, Department of Public Health, School of Medicine
2018.04- Professor, Master Program in Applied Molecular Epidemiology
Taipei Medical University, Taiwan
Introduction
I graduated from Institute of Occupational Medicine and Industrial Hygiene, National Taiwan University, where I got a Doctor of Philosophy Degree in Industrial Hygiene in 2006. I have worked as an environmental health and safety consultant in Foundation of Taiwan Industry Service in Taipei, Taiwan, a research fellow in Department of Environmental Health, Harvard School of Public Health, and an assistant professor in Department of Nursing, St. Mary’s Medicine, Nursing and Management College. I am now working as a professor in Department of Public Health, School of Medicine, College of Medicine, Taipei Medical University.
Our lab focuses on intervention studies to reduce air pollution exposure and improve human health. From 2015 to 2020, our lab found that traffic-related fine particles (PM2.5) were associated with autonomic alteration. Commuting modes could modify the effects of PM2.5 on heart rate variability (HRV) indices among young, healthy subjects. The personal exposure levels to PM2.5 were the highest in the walking commuters. The effects of PM2.5 on HRV indices were the lowest in the subway commuters compared to the effects in the walking commuters. For indoor air pollution exposure and human health, our lab found that indoor air pollution exposure was associated with systemic inflammation, oxidative stress and elevated blood pressure. The long-term filtration of indoor air pollution with an air conditioner filter was associated with cardiovascular health improvement of adults. Moreover, our lab found that houseplants could reduce indoor particulate air pollution and improve respiratory health among health adults. However, the presence of houseplants was associated with indoor ozone, isoprene and peak expiratory flow rate variations in the summer. Therefore, we recommend that the indoor temperature should be maintained below 30 degrees Celsius to avoid an increase in ozone concentration. From 2019 to 2022, the coronavirus disease 2019 (COVID-19) outbreak is a public health emergency of international concern. people are racing to buy face masks, especially medical masks to protect themselves from infection. It has led to a medical mask shortage around the world and may result in shortage of medical mask for people in need. Our team investigated whether cotton mask worn by respiratory infection person could suppress respiratory droplet levels compared to medical mask. We found that cotton mask could be a potential substitute for medical mask for respiratory infection person in microenvironment with air conditioning. Healthy people may daily use cotton mask in the community since cotton mask is washable and reusable.
Research interests
- Air pollution sampling and analysis
- Environmental epidemiology
- Workplace monitoring
Requirements and details
Scholarship availability
Taiwan Experience Education Program, TEEP (MOE) | |
International Internship Pilot Program, IIPP (NSTC) | More info |

Tuyen Van Duong, Assistant Professor
School of Nutrition and Health Sciences, College of Nutrition
Office of Global EngagementMentor profile
Education
PhD, School of Public Health, College of Public Health and Nutrition
MNSc, Graduate Institute of Nursing
Taipei Medical University, Taiwan
BNSc, School of Nursing
Hanoi Medical University, Vietnam
Professional Appointments
2023- Joint-Appointment Assistant Professor, International Master/Ph.D. Program in Medicine
2019.12.02- Assistant Professor, School of Nutrition and Health Sciences
Taipei Medical University, Taiwan
2022-2024 Chair of the Research Standards Committee
International Health Literacy Association, USA
Introduction
Dr. Duong is currently an Assistant Professor of School of Nutrition and Health Sciences, Taipei Medical University, Taiwan (from 2019). He has been serving as a president of Asian Health Literacy Association, Geneva, Switzerland (1/2025-12/2026); Elected Chair of Scientific Standards Committee, and EB member of International Health Literacy Association, Boston, USA (1/2022-12/2024). He has been invited as a yearly Guest Lecturer of Tufts University School of Medicine since 2018. He is an active member of several international organizations, e.g. Nutrition Society of Taiwan, American Society for Nutrition, and some others.
Dr. Duong has developed a strong academic background, and wide international networks. He has been closely working with other scholars on several research projects (e.g. Health and dietary literacy, dietary intake and health-related behaviors, mental health and quality of life in hemodialysis, chronic kidney disease, stroke, hypertension, diabetes mellitus and COVID-19, marriage and childbearing intention and realization) in Asian countries, and also collaborated with the research consortium in Europe and with growing number of institutions in Australia, United States and Africa.
By Jan 2025, Dr. Duong has published about 75 original research articles in more than 30 internationally indexed journals. He has been serving as an Editor of Annals of Medicine, Scientific Reports, Health Promotion International, Frontiers in Nutrition and Frontiers in Psychology, Nutrients, a reviewer of 40 international journals. He has received 16 honorable academic awards from national and international organizations from Australia, Indonesia, Malaysia, Switzerland, Taiwan, United States, Thailand, and Vietnam.
Lab members are those studying MSc, PhD programs in and out Taiwan. Some alumni continue to work and publish more papers.
Some outstanding members among others.
- Nguyen Hoang Minh: https://www.researchgate.net/profile/Minh-Nguyen-Hoang
- Pham Minh Thu: https://www.researchgate.net/profile/Thu-Pham-48
- Dang Thi Loan: https://www.researchgate.net/profile/Loan-Dang-7
- Tran Tuan Tu: https://www.researchgate.net/profile/Tran_Tu13
- Nguyen Thi Phuong Thao: https://www.researchgate.net/profile/Thao-Nguyen-Thi-Phuong-2
- Le Duc Huy: https: //www.researchgate.net/profile/Huy-Le-Duc-3
- Nguyen Thi Hong Nhi: https://www.researchgate.net/profile/Nhi-Nguyen-44
- Hoang Thi Ngoc Anh: https://www.researchgate.net/profile/Thi-Ngoc-Anh-Hoang
- Quach Ha Linh: https://www.researchgate.net/profile/Ha-Linh-Quach
Research interests
- Dietary intake, nutritional markers, metabolic syndrome, cardiovascular risks, and mortality in hemodialysis, peritoneal dialysis patients.
- Epidemiology studies on hypertension, chronic kidney diseases, diabetes, stroke, COVID-19.
- Evaluation of research instruments.
- (e-) Health literacy, (e-) healthy diet literacy.
- Lifestyles, mental health, health-related quality of life research.
Requirements and details
Scholarship availability
Taiwan Experience Education Program, TEEP (MOE) | |
International Internship Pilot Program, IIPP (NSTC) | More info |

Kai-Cheng Hsu, Professor
Master Program in Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology
Office of Global EngagementMentor profile
Education
Ph.D., Institute of Bioinformatics and Systems Biology
Master, Institute of Bioinformatics
B.S., Department of Biological Science and Technology
National Chiao Tung University, Taiwan
Professional Appointments
2022- Professor, Master Program in Clinical Genomics and Proteomics
2022- Professor, International Ph.D. Program for Translational Science
Taipei Medical University, Taiwan
Introduction
Dr. Kai-Cheng Hsu obtained his Ph.D. degree under Professor Jinn-Moon Yang in 2011. He completed his post-doctoral fellowship training under Professor Jinn-Moon Yang, where he designed software and proposed novel strategies for drug design. He then completed an assistant research fellowship at the Center for Bioinformatics Research at National Chiao Tung University. Next, He joined Taipei Medical University in 2015 as an assistant professor and received a promotion to professor in 2022.
Dr. Hsu ‘s research interests include drug discovery and rational drug design. He developed new tools for protein-ligand docking, virtual screening, and lead optimization, such as iGEMDOCK and SiMMap. Dr. Hsu also proposed pathway-based screening strategies for multitarget inhibitors of diverse proteins in metabolic pathways and a parallel screening strategy of wild-type and drug-resistant targets for anti-resistance inhibitors. Incorporating new tools and strategies, his team has identified 60 novel inhibitors targeting various proteins. Currently, his lab focuses on designing new kinase inhibitors for cancer and neuro disorders. His team has identified novel inhibitors targeting 80 kinases, 20 of which inhibit the targeted kinases within <10 nM. His work has been published 95 papers in various SCI journals and yielded 3 patents. Traditional small-molecule drug development requires immense financial resources and extensive time commitment. Unfortunately, these requirements are coupled with a low success rate. Establishing an artificial intelligence (AI) platform for drug design has the potential to reduce the demanding development time and cost seen in traditional drug development pipelines. Our team has developed an AI platform for drug design and discovery. The platform establishes various models targeting the four phases of drug development: (1) Hit identification; (2) Lead optimization; (3) Cytotoxicity prediction; and (4) ADME prediction. In hit identification, the platform has various models that can predict potential inhibitors for protein kinases with an average accuracy of 85%. For lead optimization, the platform designs one million compound derivatives and selects the most promising derivatives for synthesis. 12 cancer cell models have been established to predict compound cytotoxicity with an average accuracy of 90%. Finally, the platform for the ADME prediction phase can predict a compounds’ ability to pass the blood-brain barrier with an accuracy of 96%. Our platform can also predict acute toxicity, immunotoxicity, and mutagenicity with an accuracy of 83.8%, 84.2%, and 84%, respectively. Our work has yielded novel nanomolar inhibitors targeting 80 kinases, 20 of which inhibit the targeted kinases with IC50 values of <10 nM. We believe that our platform can accelerate different stages of drug development, reduce costs, and increase the success rate for new drugs. [/av_toggle] [av_toggle title='Research interests' title_open='' tags='' title_pos='' slide_speed='' custom_id='' aria_collapsed='' aria_expanded='' av_uid='av-2f2dh7u' sc_version='1.0']
- Structure-based drug discovery and design
- AI-driven drug design
- Kinase inhibitors
- Bioinformatics
- Cheminformatics
Requirements and details
Scholarship availability
Taiwan Experience Education Program, TEEP (MOE) | |
International Internship Pilot Program, IIPP (NSTC) | More info |

Chi-Chen Huang Associate, Professor
Ph.D. Program in Medical Neuroscience, College of Medical Science and Technology
Office of Global EngagementMentor profile
Education
Ph.D. The Institute of Basic Medical Science
M.S. Department Of Pharmacology
National Cheng-Kung University
B.A. School of Pharmacy
Taipei Medical University, Taiwan
Professional Appointments
2019- Associate Professor, The Ph.D. Program for Neural Regenerative Medicine
2014- Department of Pharmacology, College of Medicine
Taipei Medical University, Taiwan
Introduction
Dr. Huang is an University Associate Professor in Ph.D. Program in Medical Neuroscience at Taipei Medical University. After she graduated from Taipei Medical University, she got the pharmacist license and involved in the research about the pharmacology and molecular mechanism of cervical cancer during her master and Ph. D. research in National Cheng-Kung University. In her postdoctoral fellow in Academia Sinica, she was interested in neurodegenerative diseases, and focused on studying the pathological protein TDP-43 in both frontotemporal lobar degeneration (FTLD) with ubiquitin inclusions (FTLD-U) and amyotrophic lateral sclerosis (ALS). Now she is an associate professor in Taipei Medical University, and she continues her interest in exploring more molecular mechanism of TDP-43 in neural-related diseases.
Our previous studies focused on identifying the physiological function and neuropathies of the neurodegenerative disease-related pathological TDP-43. Also, we endeavor to explore potential therapeutic strategy specifically targeting on ameliorating TDP-43-related proteinopathies. Unrevealing these underlying mechanism is thus essential to provide more comprehensive understanding about TDP-43 neuropathies.
TDP-43: TDP-43 is identified as the major component of the ubiquitin positive inclusion in the frontotemporal lobar degeneration (FTLD-U) and amyotrophic lateral sclerosis (ALS) neurodegenerative diseases, suggesting the mismetabolism of TDP-43 protein is the major cause for the pathological TDP-43 aggregates formation. However, the comprehensive picture of the metabolism and mis-metabolism of TDP-43 protein itself in normal cells remains unclear. We provide a comprehensive model of the metabolism and mismetabolism of TDP-43 in relation to these findings is presented in J. Cell. Sci. 2014. In addition, we also discovered the impact of loss-of-function of TDP-43 on autophagy regulation which contributes to the development of TDP-43 proteinopathies. Our works was presented in J. Biol. Chem. 2011. We also explore the detailed therapeutic mechanism of traditional herb medicine berberine on TDP-43 proteinopathy which provides an candidate drug targeting with less side effect potentially developed as an alternative therapy for TDP-43-related neuropathology in FTLD and ALS (J Biomed Sci, 2016) (104-2320-B-038-054-MY3). Moreover, we have identified Znf179 as an E3 ubiquitin ligase for TDP-43 and demonstrated the ZNF-179-mediated regulatory mechanism in TDP-43 metabolism and TDP-43-related proteinopathies. A better understanding of the function of the novel E3 ligase, Znf179, and the correlation between Znf179 and TDP-43 will provide a new therapeutic avenue for the ALS and FTLD-U patients in the future (J Biomed Sci, 2018)(104-2320-B-038-054-MY3). In clinical trial, we have demonstrated the elevation of plasma TDP-43 in the exosome may develop as a potential biomarker for the diagnosis of ALS patients (J. Neurol. Sci. 2020). Moreover, in our phase II clinical trial, we found that the add-on therapy of tamoxifen mildly attenuates the disease progression in the first 6 months, implicating the benefit role of tamoxifen for the early disease onset ALS patients (Medicine, 2020). Not only in FTLD and ALS, we discovered that TDP-43 also plays a role in ischemia stroke and involved in rapamycin-mediated therapeutic effect in ischemia stoke disease model (Int J Mol Sci. 2022)(110-2320-B-038-067-MY3). To explore the specific way to target TDP-43 for proteasome degradation, we dedicated to unravel the role of TNKS-mediated ADP-ribosylation of TDP-43 and TNKS-PI31 signaling cascade for the activity regulation and axonal transportation of 20S proteasome under normal condition and TDP-43-related neuropathies (Manuscript is in preparation) (110-2320-B-038-067-MY3). Overall speaking. we provide a better understanding of the TDP-43 proteinopathies and open a new therapeutic avenue for ALS and FTLD-U patients.
Research interests
- Neurodegenerative disease
- Neuromolecular biology
- Post-translational modification
Requirements and details
Scholarship availability
Taiwan Experience Education Program, TEEP (MOE) | |
International Internship Pilot Program, IIPP (NSTC) | More info |

Chih-Wei Huang, Associate Research Fellow
College of Medical Science and Technology
Office of Global EngagementMentor profile
Education
Ph.D., Graduate Institute of Biomedical Informatics
M.S., Graduate Institute of Biomedical Informatics
B.A., School of Healthcare Administration
Taipei Medical University, Taiwan
Professional Appointments
2023- Adjunct Assistant Professor, Graduate Institute of Biomedical Informatics
2022- Associate Research Fellow, International Research Center for Health Information Technology, School of Medical Science and Technology
2022- Adjunct Research Fellow, Center for Education in Medical Simulation
Taipei Medical University, Taiwan
Introduction
Dr. Chih-Wei (Grace) Huang graduated from the Doctoral Program in Medical Informatics at Taipei Medical University in 2016 and served as a full-time Assistant Research Fellow at the International Research Center for Health Information Technology of the College of Medical Science and Technology, Taipei Medical University since 2018. Dr. Huang was promoted to Associate Research Fellow in 2022. To date, Dr. Huang has published 43 SCI/EI journal papers, with 6 as the first or corresponding author, and has participated in over 30 funded projects (including research, industry-academic collaborations, and scientific innovation projects), serving as the principal investigator for 3 of these projects. Dr. Huang has also been involved in over 10 patent applications, co-inventing 2 patents (applications in Taiwan and the U.S. for invention patents and a new type of patent in Taiwan). In 2020, Dr. Huang was appointed as a startup consultant for the SPARK program at Taipei Medical University and established the Digital Health Translation (DHT) initiative to assist with field validation and clinical data verification, linking resources for industry talent training and industry-academic collaboration platforms.
Dr. Huang’s research focus is on “Digital Health Care for Chronic Kidney Disease,” with doctoral research on “Visualizing Disease Trajectories through Big Data” focusing on chronic kidney disease, Taiwan’s new national disease. In collaboration with Professor Kuan-liu Ma from the Data Visualization Center at the University of California, Davis, this work utilized time-series, multi-dimensional big data analysis, and interactive information visualization systems to track the disease progression of a research cohort over 13 years, providing researchers and clinicians with new perspectives and evidence for precise prevention and care. Subsequently, Dr. Huang has continued to delve into applying data analysis and machine learning for the prevention of comorbidities in chronic kidney disease and dialysis patients, drug dosage recommendations, personalized health education information, and wearable device interventions. The project titled “Constructing an Intelligent Erythropoiesis-Stimulating Agent Dosing Model for Patients with Chronic Kidney Disease Using Electronic Medical Records and Personal Health Information” received consecutive funding for two years (2019 and 2020) from the Ministry of Science and Technology (MOST 108-2410-H-038-010-SSS, 109-2410-H-038-007-), utilizing retrospective data (from Wanfang Hospital, Taipei, Tunghai Hospital, Taichung, and the Clinical Data Database of Taipei Medical University) and deep learning to establish an intelligent dosing prediction model. Furthermore, aiming to further construct personalized health education models through behavioral science to enhance patients’ health literacy and disease awareness, Dr. Huang supervised two students from the Department of Gerontological Health Management in obtaining the Ministry of Science and Technology undergraduate project grants in 2021 and 2022, with projects titled “Health Literacy and Smart Bracelet Intervention as Important Factors and Preliminary Exploration of the Effects on Physical Activity of Elderly Dialysis Patients in Taiwan (NSTC 110-2813-C-038-199-H)” and “Evaluating the Effectiveness of Personalized Health Education Information Delivery via the LINE Platform for Middle-aged and Elderly Dialysis Patients (NSTC 111-2813-C-038-013-H),” leading to the presentation of research results at international academic conferences and receiving honors. Currently, Dr. Huang is working on the project “Developing a Multimodal Personalized Osteoporosis Fracture Risk Prediction Model for Dialysis Patients Using Clinical Phenotypes and Wearable Physiological Measurement Data (NSTC 112-2410-H-038-011-),” aiming to establish a personalized fracture risk prediction and assessment tool through multicenter clinical databases and field case collection, with clinical validation expected.
Research interests
- Digital Health Intervention Research
- Artificial Intelligence in Medicine
- Big Data and Visual Analytics in Health and Medicine
- Health Informatics and Information Management
Requirements and details
- Proficiency in programming languages such as Python or R, with experience in libraries/frameworks like TensorFlow, PyTorch, or Scikit-learn.
- Strong knowledge of machine learning, deep learning, and statistical analysis techniques.
- Hands-on experience with healthcare datasets, including EMR or wearable device data.
- Excellent problem-solving skills and the ability to communicate technical findings effectively to non-technical audiences.
- Strong written and verbal communication skills in English.
Scholarship availability
Taiwan Experience Education Program, TEEP (MOE) | |
International Internship Pilot Program, IIPP (NSTC) | More info |

Wei-Chun HuangFu, Associate Professor
Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology
Office of Global EngagementMentor profile
Education
Ph.D., Molecular and Cellular Toxicology
North Carolina State University, USA
MEM, Nicholas School of the Environment and Earth Sciences
Duke University, USA
B.S. in Atomic Science
National Tsing-Hua University, Taiwan
Professional Appointments
2024.02- Director, Graduate Institute of Cancer Biology and Drug Discovery
2019- Associate Professor, Graduate Institute of Cancer Biology and Drug Discovery
Taipei Medical University, Taiwan
Introduction
Dr. Wei-Chun HuangFu received her BSc from National Tsing-Hua University, her MSc from Duke University, and her PhD from North Carolina State University. She completed her postdoctoral training at the University of Pennsylvania, USA. She is currently an Associate Professor at the Graduate Institute of Cancer Biology and Drug Discovery and the Vice Dean for International Affairs of the College of Medical Science and Technology (CoMST) at Taipei Medical University, Taiwan. She is dedicated to drug discovery, drug pharmacology, and efficacy evaluation, as well as investigating their mechanism of action.
Research interests
- Cancer Biology
- Signal Transduction
- Molecular Toxicology
Requirements and details
Scholarship availability
Taiwan Experience Education Program, TEEP (MOE) | |
International Internship Pilot Program, IIPP (NSTC) | More info |

Yi-Chen Hsieh, Professor
Ph.D. Program in Medical Neuroscience, College of Medical Science and Technology
Office of Global EngagementMentor profile
Education
Ph.D. in Public Health
M.S. in Public Health
Taipei Medical University, Taiwan
Professional Appointments
2022- Professor, Master Program in Applied Molecular Epidemiology
2022- Professor, The Ph.D. Program for Neural Regenerative Medicine
Taipei Medical University, Taiwan
Introduction
Dr. Hsieh has received her doctoral and postdoctoral training in Public Health in Taipei Medical University. Currently, she is a professor at the Ph.D. Program in Medical Neuroscience at Taipei Medical University (TMU), focusing on utilizing epidemiological methods to establish large-scale cohort and investigating risk factors and molecular or genetic biomarkers related to neurodegenerative diseases.
Research interests
- Molecular epidemiology on stroke and cancer
- Genetic epidemiology on stroke and cancer
Requirements and details
Scholarship availability
Taiwan Experience Education Program, TEEP (MOE) | |
International Internship Pilot Program, IIPP (NSTC) | More info |

Shu-Huei Kao, Professor
School of Medical Laboratory Science and Biotechnology, College of Medical Science and Technology
Office of Global EngagementMentor profile
Education
Ph.D. in Biochemistry and Molecular Biology
M.S. in Biochemistry and Molecular Biology
National Yang-Ming University, Taiwan
B.S. in Medical Technology
Taipei Medical University, Taiwan
Professional Appointments
2023- Deputy Dean, College of Medical Science and Technology
2019- Professor, Ph.D. Program in Medical Biotechnology, School of Medical Laboratory Science and Biotechnology
2019- Professor, School of Medical Laboratory Science and Biotechnology
Taipei Medical University, Taiwan
Introduction
Dr. Shu-Huei Kao received her doctoral degree in Biochemistry and Molecular Biology, emphasizing mitochondrial health in human reproduction in 2002 from the National Yang-Ming University, Taiwan. Then, she joined Taipei Medical University (TMU) as a tenure-track Assistant Professor in 2000 and was promoted to Associate Professor in 2008 and full Professor in 2019.
She is currently a Professor at the School of Medical Laboratory Science and Biotechnology. She is the Vice Dean for Education Affairs of the College of Medical Science and Technology (COMST) at Taipei Medical University, Taiwan. She is dedicated to diagnosis of the rare diseases and reproductive technology-assisted treatments.
Research interests
- Reproductive Medicine
- Mitochondrial Medicine
Requirements and details
Scholarship availability
Taiwan Experience Education Program, TEEP (MOE) | |
International Internship Pilot Program, IIPP (NSTC) | More info |

Jiunn-Horng Kang, Professor
Graduate Institute of Nanomedicine and Medical Engineering, College of Biomedical Engineering
Office of Global EngagementMentor profile
Education
Ph.D., Department of Biomedical Engineering
M.S., Graduate Institute of Clinical Medicine, College of Medicine
M.D., School of Medicine
National Taiwan University, Taiwan
Professional Appointments
2021.08- Dean, College of Biomedical Engineering
2021- Professor, Graduate Institute of Nanomedicine and Medical Engineering, College of Biomedical Engineering
Taipei Medical University, Taiwan
Introduction
His research focuses on applying an engineering perspective to assist rehabilitation, including areas such as stroke and chronic pain. His research files include brain neuron imaging to identify pain disorders and stroke, using new technology (such as wearable devices and markerless system) to conduct motion analysis during rehabilitation, and the establishment of medical prediction models using large clinical databases.
Our lab is at the forefront of engineering innovative solutions to aid rehabilitation for conditions like stroke and chronic pain.
We delve into groundbreaking research areas, including brain neuron imaging to detect pain disorders and stroke.
By leveraging cutting-edge technology, such as wearable devices and markerless systems, we conduct detailed motion analyses to enhance rehabilitation processes.
Moreover, our lab specializes in developing predictive medical models by analyzing extensive clinical databases.
Our work aims to bridge engineering and medical sciences to improve rehabilitation techniques and patient outcomes.
Research interests
- Pain medicine
- Electrophysiology
- Neuroscience
- Nonlinear analysis
Requirements and details
We welcome from undergraduate and graduate students with strong motivation to learn.
Scholarship availability
Taiwan Experience Education Program, TEEP (MOE) | |
International Internship Pilot Program, IIPP (NSTC) | More info |

Nai-Wen Kuo, Professor
School of Health Care Administration, College of Management
Office of Global EngagementMentor profile
Education
Ph.D. in Health Policy and Management, The Johns Hopkins University (USA)
M.P.H. in Health Administration, Yale University (USA)
B.P.H., National Taiwan University
Professional Appointments
- 2021.1- Dean, College of Management, Taipei Medical University
- 2009- Professor, School of Health Care Administration, Taipei Medical University
- 2003-2009 Associate Professor, School of Health Care Administration, Taipei Medical University
Introduction
Professor Nai-Wen Kuo took office as the Dean of the College of Management on January 01, 2021. Before that, he served as the Dean of the College of Public Health. Under his leadership, the TMU College of Public Health became a critical think tank of the Taiwan Ministry of Health and Welfare. He assists the Taiwan Center for Disease Control in expanding its international cooperation network, including collaborations with the Johns Hopkins Center for Health Security and a TB Control and Prevention Project with the Quang-Ninh Province of Vietnam. The TMUCPH also partnered with world-renowned universities, such as the Johns Hopkins Bloomberg School of Public Health, Yale University, and the National University of Singapore.
Dean Kuo has managed Taipei Medical University’s international affairs from October 2011 to August 2016. During his term as the Dean of International Affairs, he was responsible for all aspects of TMU’s international activities, including foreign student recruitment, counseling, related services, international student and faculty exchanges, partner university relations and communications, international research collaborations, and medical mission operations.
He joined the university in 1997 as a professor of Health Care Administration. Before serving as Dean of International Affairs, he was appointed to many important positions within and beyond the university, including terms as TMU Press Director, Director of the School of Health Care Administration, the university’s Chief Secretary, Advisor to Taipei City Hospital, and as Chief Surveyor for Hospital Accreditation appointed by the Ministry of Health and Welfare.
Dean Kuo previously served as Deputy Chief Executive Officer of Taipei City Hospital, a 4200-bed, nine-hospital system operated by the capital city’s government. His primary responsibilities in this role included daily managing operations of a major hospital system, including quality improvement projects and financial analyses. Dean Kuo also served as Vice Superintendent of Taipei Medical University Hospital from 2000 to 2002. Under his management, this hospital turned a history of losses into its first profit-making year in 2002.
Dean Kuo is among Taiwan’s few healthcare administration educators who have held numerous leadership positions. He serves on the board of directors of critical academic societies such as the Taiwan College of Healthcare Executives. Dean Kuo’s research interests include healthcare quality, clinical pathways, patient safety, and healthcare facility design. Dean Kuo authorizes over 70 publications, including journal articles, conference papers, and technical reports.
He received his Ph.D. in Health Policy and Management from Johns Hopkins University in 1997, following his 1992 MPH in Health Care Administration from Yale University. He also served as a Fulbright Scholar at the University of Illinois at Urbana-Champaign from 2009 to 2010.
We closely cooperate with the International Society of Quality in Health Care (ISQua) and Taiwan Joint Commission in the field of patient safety and healthcare quality improvement.
In the past, advisees of Dr. Kuo have devoted themselves to research on hospital patient safety culture in many countries, including Vietnam, Belize, Gambia, Eswatini, the Republic of Marshall Island, etc. We also utilize some US government open data to research the incidence rates of central line-associated bloodstream infection in California community hospitals and published on the PLOS One.
Research interests
- Healthcare Quality Management
- Healthcare Marketing
- Strategic Management in Healthcare Organizations
- Healthcare Facility Design
- Patient Safety
Requirements and details
Scholarship availability
Taiwan Experience Education Program, TEEP (MOE) | |
International Internship Pilot Program, IIPP (NSTC) | More info |

Shu-Yu Kuo, Professor
School of Nursing, College of Nursing
Office of Global EngagementMentor profile
Education
Ph.D., Institute of Epidemiology, National Taiwan University, Taiwan
Professional Appointments
- 2024.09- Deputy Director, Department of Nursing, Taipei Medical University Hospital
- 2024.08.01- Vice Dean, College of Nursing, Taipei Medical University
- 2022.12- Professor, International Ph.D. Program in Gerontology and Long-Term Care, Taipei Medical University
Introduction
Prof. Shu-Yu Kuo is a professor in the School of Nursing at the Taipei Medical University, Taipei, Taiwan. Prof. Kuo is active in maternal and child health studies, nursing simulation education, and awards for excellence in teaching at TMU. Prof. Kuo has had clinical experiences in high-risk perinatal care in the US and Taiwan and has been devoted to nursing clinical and academic education and research over the years. She is an advisor to international students from Indonesia, Vietnam, and Malawi and has researched maternal and child health, breastfeeding practices, and perinatal mental health studies.
Welcome to the maternal and child health lab at TMU. We are clinical practitioners and researchers who focus on integrated childbirth education intervention, breastfeeding educational intervention, trajectories of physical and psychological symptoms during pregnancy, topics on child health, and simulation education.
Research interests
- Maternal and Child Health
- Epidemiology
- Women Health
- Perinatal Health
- Breastfeeding
- Nursing Education
- Mental Health
Requirements and details
Scholarship availability
Taiwan Experience Education Program, TEEP (MOE) | |
International Internship Pilot Program, IIPP (NSTC) | More info |

Kuei-Hung Lai, Assistant Professor
Ph. D. Program in the Clinical Drug Development of Herbal Medicine, College of Pharmacy
Office of Global EngagementMentor profile
Education
Ph.D., Division of Pharmacognosy, Uppsala University, Sweden
Ph.D., Graduate Institute of Natural Products, Kaohsiung Medical University, Taiwan
B.S., Department of Life Science, National Chung Cheng University, Taiwan
Professional Appointments
- 2023- Associate Professor, Ph. D. Program in the Clinical Drug Development of Herbal Medicine, College of Pharmacy, Taipei Medical University
- 2023- Associate Professor, Graduate Institute of Pharmacognosy, College of Pharmacy, Taipei Medical University
- 2021-2023 Assistant Professor, Ph. D. Program in the Clinical Drug Development of Herbal Medicine, College of Pharmacy, Taipei Medical University
Introduction
Cheng-Chung Lee is an Associate Research Fellow in the Ph.D. Program for Translational Medicine at Taipei Medical University, Taiwan. Dr. Lee’s academic background lies in chemistry and structural biology. He initiated his research journey in protein crystallography and protein engineering during his Ph.D. studies at the Institute of Biochemistry and Molecular Biology, School of Life Sciences, National Yang Ming University, Taiwan. His doctoral research aimed to elucidate the 3D structure of infectious bursal disease virus (IBDV) viral particles using X-ray crystallography, contributing significantly to identifying functional epitopes on particle surfaces for vaccine design. Continuing his exploration in structural biology and virology, Dr. Lee pursued postdoctoral research at the Institute of Biological Chemistry, Academia Sinica, Taiwan, from 2008 to 2011. Building upon this experience, he redirected his focus towards enzyme engineering in the biofuel field and the study of viral neutralization antibodies. From 2011 to 2015, Dr. Lee served as a Project Manager at the Core Facilities for Protein Structural Analysis (CFPSA), where he continued his research work and technical development. In 2016, he was promoted to Senior Research Scientist at the Taiwan Protein Project (TPP) and subsequently transitioned to the Technology Supporting Platform Axis (TSPA) at Academia Sinica, Taiwan, where he remained from 2020 to 2022.
Our Structural BioMed Laboratory is dedicated to advancing structure-based protein engineering for developing highly applicable protein molecules. Our research focuses on enzymes in synthetic biology and antibodies for diagnostic and therapeutic applications. We have established antibody engineering platforms and developed potential therapeutic antibodies, including, antibody-conjugated sEVs (CAR-sEVs), antibody-drug conjugation (anti-Her2 ADC), antibody affinity maturation (anti-IL-1β), and source substitution (humanization).
Currently, we are interested in autoimmune diseases. Autoimmune diseases result from the immune system mistakenly attacking healthy cells and tissues, leading to chronic inflammation and organ dysfunction. Our efforts are focused on developing antibodies for detecting and treating autoimmune diseases in humans.
Research interests
- Natural product chemistry on fungi, plants, and marine organisms.
- Comparative mass spectrometry-based metabolomics strategies for the investigation of natural products secondary metabolites.
- Functional and healthy food, new drug development.
Requirements and details
Preferred Intern Education Level
BS/MS/ PhD in Life Science
Skill sets or Qualities
Priority consideration will be given to students with a background in structural biology.
Scholarship availability
Taiwan Experience Education Program, TEEP (MOE) | |
International Internship Pilot Program, IIPP (NSTC) | More info |

Carlos Shu Kei Lam (Shu-Kee Lin), Associate Professor
Department of Emergency, College of Medicine
Office of Global EngagementMentor profile
Education
Ph.D., School of Public Health, College of Public Health
M.S., Graduate Institute of Injury Prevention and Control, College of Public Health and Nutrition
Taipei Medical University, Taiwan
M.D., School of Medicine, College of Medicine
China Medical University, Taiwan
Professional Appointments
- 2024.02- Professor, College of Medicine, Taipei Medical University, Taiwan
- 1998- Attending Physician, Emergency Department, Wan Fang Hospital, Taipei Medical University, Taiwan
Introduction
Dr. Carlos Shu Kei Lam (Shu-Kee Lin) holds the position of Professor at the School of Medicine, College of Medicine, Taipei Medical University, Taiwan. He earned his PhD in Public Health in 2020, a Master’s Degree in Medical Science in 2002, and a Bachelor of Medicine in 1985. In 2006, he was granted a clinical fellowship at the emergency department of Sir Mortimer B. Davis – Jewish General Hospital, McGill University, Canada.
Dr. Lam attained his specialization in surgery in 1990, followed by specialization in emergency medicine and critical medicine in 1999 and 2010, respectively. Serving as an attending physician at the emergency department of Wan Fang Hospital, Taipei Medical University, since 1998, he assumed the role of director of the department from 2008 to 2014. At present, he is the director for the Resident Training Program.
Dr. Lam’s laboratory has recently undertaken significant research initiatives, focusing on:
1. Establishment of Predictive Models for Prognosis among Pneumonia Patients
Addressing a crucial aspect of personalized precision medicine, we predict clinical deterioration post-hospital or emergency department discharge. Amidst post-COVID-19 challenges, ED overcrowding is a concern. Thus, our research involves establishing predictive models for adverse outcomes in patients with lower respiratory tract infections, employing machine learning to forecast 30-day readmission.
2. The Post Traumatic Recovery Cohort-Taiwan (PTRC-Taiwan)
With Taiwan embracing an aging society, we explore the impact of pre-existing conditions on functional outcomes in elderly trauma patients. By conducting a prospective cohort study, we aim to understand the connection between pre-injury health conditions, such as pre-existing diseases and frailty, and subsequent functional decline.
3. GIS Analysis of Environmental Risk Factors on Road Traffic Injuries
Unraveling the complexities of road traffic accidents, we delve into the influence of environmental factors. Beyond road-related aspects, we investigate the interplay of air quality, weather conditions, and injury severity in road traffic injuries (RTIs). Using Geographical Information System (GIS), our research seeks to establish associations between environmental factors and injury outcomes.
Under Dr. Lam’s guidance, our mentored medical students have achieved remarkable accomplishments. One student secured a research grant from the National Science and Technology Council and received an honorable mention at the Taipei Medical University Teachers and Students Joint Academic Research Symposium. Collaborating with Dr. Lam, the student co-authored two SCI papers. Moreover, another medical student is exploring the risk of subsequent traumatic intracranial hemorrhage post-new stroke. This research has been accepted for oral presentation at the 18th World Congress of Neurosurgery Symposium and will be submitted for publication soon.
Currently, four medical students are actively engaged in research within Dr. Lam’s lab. Among them, three are examining the connections between air pollution and RTIs, while one is investigating the risk factors contributing to functional decline among trauma patients.
Research interests
- Predicting Clinical Deterioration Post-Hospital/ED Discharge in Pneumonia Patients
- Unveiling Functional Trajectory Post-Hospitalization for Trauma Patients
- Examining the Impact of Air Pollution on Trauma Cases
- Spinal Cord Injury Epidemiology
- Road Traffic Injury Epidemiology
- Motorcycle Injury Epidemiology
- Emergency Medicine
- Injury Prevention
Requirements and details
Scholarship availability
Taiwan Experience Education Program, TEEP (MOE) | |
International Internship Pilot Program, IIPP (NSTC) | More info |

Quoc Khanh Le Nguyen, Associate Professor
Professional Master Program in Artificial Intelligence in Medicine, College of Medicine
Office of Global EngagementMentor profile
Education
Ph.D., Computer Science & Engineering
M.S., Computer Science & Engineering
Yuan Ze University, Taiwan
B.Eng., Information Technology
Da Lat University, Vietnam
Professional Appointments
2023.02- Associate Professor, International Master/Ph.D. Program in Medicine, College of Medicine
2023.02- Associate Professor, Professional Master Program in Artificial Intelligence in Medicine
Taipei Medical University, Taiwan
Introduction
I am Le Nguyen Quoc Khanh, also known as Khanh Lee. I am an associate professor with the In-Service Master Program in Artificial Intelligence in Medicine, College of Medicine, Taipei Medical University (TMU). Prior to joining TMU, I completed a postdoctoral research program at Nanyang Technological University in Singapore. I earned my master’s and Ph.D. degrees from the Department of Computer Science and Engineering, Yuan Ze University, Taiwan. As a computer scientist and data scientist specializing in medical applications, my primary goal is to contribute to the field of artificial intelligence (AI) and its applications in medicine. My research interests are focused on AI applied to radiomics, bioinformatics, and biomedical informatics, with the goal of advancing medical imaging and genomics, using AI to predict and diagnose diseases, and improve patient outcomes.
We are AIBioMed team, a diverse group of experts from various fields, including AI, medicine, and technology. Our team is passionate about using an interdisciplinary approach to tackle complex problems from different perspectives. With my leadership and the AIBioMed team’s expertise, we have already made significant contributions to the field, publishing numerous papers in top-tier journals and presenting a variety of research at international conferences. Additionally, we have been awarded several research grants from the National Science and Technology Council (NSTC) and the Ministry of Education (MOE) in Taiwan. Recently, we are at the forefront of developing innovative solutions that have the potential to revolutionize healthcare. Our commitment to advancing the use of AI in medicine underscores our dedication to improving patient outcomes and advancing medical knowledge. Further information about our work can be found at https://khanhlee.github.io/publications/.
Research interests
- Artificial Intelligence (Machine Learning & Deep Learning)
- Bioinformatics & Computational Biology
- Genomics, Proteomics, Radiomics
- Medical informatics
Requirements and details
Preferred Intern Education Level
- Pursuing or completed a bachelor’s/master’s degree in Computer Science, Medicine, Biomedical Engineering, or a related field.
Skill sets or Qualities
- Solid understanding of computer vision and deep learning concepts.
- Familiarity with deep learning frameworks such as TensorFlow or PyTorch.
- Familiarity with medical imaging data formats and challenges is a plus.
- Strong analytical and problem-solving skills.
- Effective communication skills, both written and verbal.
- Prior research or project experience in related fields.
Scholarship availability
Taiwan Experience Education Program, TEEP (MOE) | |
International Internship Pilot Program, IIPP (NSTC) | More info |

Cheng-Chung Lee, Associate Research Fellow
The Ph.D. Program for Translational Medicine, College of Medical Science and Technology
Office of Global EngagementMentor profile
Education
Ph.D., Institute of Biochemistry and Molecular Biology
National Yang Ming University, School of Life Sciences, Taiwan.
M.S., Graduate Institute of Biotechnology
National Chung Hsing University, College of Agriculture and National Resources, Taiwan.
B.S., Department of Chemistry
Tamkang University, College of Science, Taiwan.
Introduction
Cheng-Chung Lee is an Associate Research Fellow in the Ph.D. Program for Translational Medicine at Taipei Medical University, Taiwan. Dr. Lee’s academic background lies in chemistry and structural biology. He initiated his research journey in protein crystallography and protein engineering during his Ph.D. studies at the Institute of Biochemistry and Molecular Biology, School of Life Sciences, National Yang Ming University, Taiwan. His doctoral research aimed to elucidate the 3D structure of infectious bursal disease virus (IBDV) viral particles using X-ray crystallography, contributing significantly to identifying functional epitopes on particle surfaces for vaccine design. Continuing his exploration in structural biology and virology, Dr. Lee pursued postdoctoral research at the Institute of Biological Chemistry, Academia Sinica, Taiwan, from 2008 to 2011. Building upon this experience, he redirected his focus towards enzyme engineering in the biofuel field and the study of viral neutralization antibodies. From 2011 to 2015, Dr. Lee served as a Project Manager at the Core Facilities for Protein Structural Analysis (CFPSA), where he continued his research work and technical development. In 2016, he was promoted to Senior Research Scientist at the Taiwan Protein Project (TPP) and subsequently transitioned to the Technology Supporting Platform Axis (TSPA) at Academia Sinica, Taiwan, where he remained from 2020 to 2022.
Our Structural BioMed Laboratory is dedicated to advancing structure-based protein engineering for developing highly applicable protein molecules. Our research focuses on enzymes in synthetic biology and antibodies for diagnostic and therapeutic applications. We have established antibody engineering platforms and developed potential therapeutic antibodies, including, antibody-conjugated sEVs (CAR-sEVs), antibody-drug conjugation (anti-Her2 ADC), antibody affinity maturation (anti-IL-1β), and source substitution (humanization).
Currently, we are interested in autoimmune diseases. Autoimmune diseases result from the immune system mistakenly attacking healthy cells and tissues, leading to chronic inflammation and organ dysfunction. Our efforts are focused on developing antibodies for detecting and treating autoimmune diseases in humans.
Research interests
- Study of the prodigiosin biosynthesis pathway and enzyme engineering.
- Antibody-drug conjugation for the treatment of cancer.
- Development of cytokine-specific antibodies for the treatment of inflammatory diseases.
- Investigation of anti-ANA antibodies in systemic lupus erythematosus (SLE).
Requirements and details
Preferred Intern Education Level
- BS/MS/ PhD in Life Science
Skill sets or Qualities
- Priority consideration will be given to students with a background in structural biology.
Scholarship availability
Taiwan Experience Education Program, TEEP (MOE) | |
International Internship Pilot Program, IIPP (NSTC) | More info |

Chia-Hwa Lee, Professor
School of Medical Laboratory Science and Biotechnology, College of Medical Science and Technology
Office of Global EngagementMentor profile
Education
Ph.D. in Graduate Institute of Medical Sciences
M.S. in School of Medical Laboratory Science and Biotechnology
B.S. in School of Medical Laboratory Science and Biotechnology
Taipei Medical University, Taiwan.
Introduction
Cheng-Chung Lee is an Associate Research Fellow in the Ph.D. Program for Translational Medicine at Taipei Medical University, Taiwan. Dr. Lee’s academic background lies in chemistry and structural biology. He initiated his research journey in protein crystallography and protein engineering during his Ph.D. studies at the Institute of Biochemistry and Molecular Biology, School of Life Sciences, National Yang Ming University, Taiwan. His doctoral research aimed to elucidate the 3D structure of infectious bursal disease virus (IBDV) viral particles using X-ray crystallography, contributing significantly to identifying functional epitopes on particle surfaces for vaccine design. Continuing his exploration in structural biology and virology, Dr. Lee pursued postdoctoral research at the Institute of Biological Chemistry, Academia Sinica, Taiwan, from 2008 to 2011. Building upon this experience, he redirected his focus towards enzyme engineering in the biofuel field and the study of viral neutralization antibodies. From 2011 to 2015, Dr. Lee served as a Project Manager at the Core Facilities for Protein Structural Analysis (CFPSA), where he continued his research work and technical development. In 2016, he was promoted to Senior Research Scientist at the Taiwan Protein Project (TPP) and subsequently transitioned to the Technology Supporting Platform Axis (TSPA) at Academia Sinica, Taiwan, where he remained from 2020 to 2022.
Our Structural BioMed Laboratory is dedicated to advancing structure-based protein engineering for developing highly applicable protein molecules. Our research focuses on enzymes in synthetic biology and antibodies for diagnostic and therapeutic applications. We have established antibody engineering platforms and developed potential therapeutic antibodies, including, antibody-conjugated sEVs (CAR-sEVs), antibody-drug conjugation (anti-Her2 ADC), antibody affinity maturation (anti-IL-1β), and source substitution (humanization).
Currently, we are interested in autoimmune diseases. Autoimmune diseases result from the immune system mistakenly attacking healthy cells and tissues, leading to chronic inflammation and organ dysfunction. Our efforts are focused on developing antibodies for detecting and treating autoimmune diseases in humans.
Research interests
- Cancer Research
- Molecular Oncology
- Gene Editing
- Thyroid Cancer
- Breast Cancer
- Thyroid Cancer
- Leukemia
Requirements and details
Preferred Intern Education Level
- BS/MS/ PhD in Life Science
Skill sets or Qualities
- Priority consideration will be given to students with a background in structural biology.
Scholarship availability
Taiwan Experience Education Program, TEEP (MOE) | |
International Internship Pilot Program, IIPP (NSTC) | More info |

Kuen-Haur Lee, Professor
Ph.D. Program for Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology
Office of Global EngagementResearch Interests
- Signal transduction of tumor biology
- Drug repurposing of cancer
- The roles of miRNAs in cancer
Profile: TMU Academic Hub
More information: NSTC IIPP
Mentor profile
Education
Ph.D. in Graduate Institute of Medical Sciences
M.S. in School of Medical Laboratory Science and Biotechnology
B.S. in School of Medical Laboratory Science and Biotechnology
Taipei Medical University, Taiwan.
Introduction
Name: Kuen-Haur Lee
- Professor, Ph.D. Program for Cancer Molecular Biology and Drug Discovery
- Joint-Appointment Professor, Master Program in Graduate Institute of Cancer Biology and Drug Discovery
- Member, TMU Research Center of Cancer Translational Medicine
- Member, TMU Research Center for Digestive Medicine
ORCID: https://orcid.org/0000-0002-6354-3315
Drug Repurposing and Cancer Molecular Mechanism Lab
Member in Our Lab
PhD students-Taiwan students (3 students)
Research direction: Investigation the roles of CRNDE in neuroendocrine-associated CRC
Research direction: Small molecule-induced endosomal escape of LNP-based siRNA by targeting the X-protein
Research direction: Genomics study for drug resistant of colorectal cancer
PhD students-International students (2 students)
Research direction: Identification the risk factors of EoCRC
Research direction: Investigation the functional role of CRNDE-regulated molecules or signaling in obesity- or diabetes-related EoCRC could provide novel insights to enhance targeted CRC cancer therapies.
Research interests
Research Interests
- Signal transduction of tumor biology
- Drug repurposing of cancer
- The roles of miRNAs in cancer
Requirements and details
Preferred Intern Education Level
Major in medicine or life sciences
Skill sets or Qualities
- Ability to design experiments, analyze data, and draw meaningful conclusions using statistical and bioinformatics tools.
- Proficiency in key laboratory techniques (e.g., PCR, Western blotting, cell culture, and next-generation sequencing) and experience with omics technologies.
- Solid understanding of molecular biology, biochemistry, and systems biology, with familiarity in computational biology and bioinformatics.
- Effective scientific writing and verbal communication for publications, presentations, and teamwork across disciplines.
- Flexibility to adopt new technologies and resilience to troubleshoot challenges and innovate in evolving research environments.
Scholarship availability
Taiwan Experience Education Program, TEEP (MOE) | |
International Internship Pilot Program, IIPP (NSTC) | More info |

Shu-Chun Lee, Associate Professor
School of Gerontology & Long-Term Care, College of Nursing
Office of Global EngagementMentor profile
Education
PhD, Wolfson Center for Age-Related Diseases
King’s College London, UK
MSc, Health and Rehabilitation
University of Southampton, UK
BSc, Physiotherapy, Rehabilitation Medicine
Chung Shan Medical University, Taiwan
Professional Appointments
2024.02- Director, International Ph.D. Program in Gerontology and Long-Term Care, College of Nursing
2022.12- Associate Professor, International Ph.D. Program in Gerontology and Long-Term Care, College of Nursing
Taipei Medical University, Taiwan
Introduction
Dr Shu-Chun Lee is an Associate Professor and Director in the PhD Program in Gerontology and Long-Term Care at Taipei Medical University, Taiwan. She was trained as a physiotherapist and her specialty is neurological and geriatric physiotherapy. She completed her Master degree at University of Southampton and PhD degree at King’s College London in the United Kingdom. Her research interests are geriatric syndromes, particularly sarcopenia and frailty, balance and gait, falls and fear of falling. She makes use of various methods to answer research questions such as 1) utilizing clinical assessment and laboratory-based examination (i.e EMG, inertial sensors) to characterize movement, 2) analyzing population-based health databases, 3) developing or examining potential interventions such as physical exercise training to reduce aging-related health problems. Dr Lee is a lead investigator on many research projects and keen on international research collaborations. Please see https://orcid.org/0000-0002-5982-347X for my latest research projects and publications.
The modern world is facing an unprecedented challenge of aging populations, even in low-to-middle-income countries. Taiwan became an aged society in 2018 and is on schedule to become a super-aged society by 2025. Promoting healthy aging is of the utmost importance. Maintaining functional capacity and preventing geriatric syndromes is the key to staying healthy. The Aging, Mobility, and Health Lab focuses on sarcopenia, frailty, mobility impairment, and falls. Students participating in this program will learn to 1) use population-based national databases to analyze the physical, mental and psychosocial conditions in older population; 2) use laboratory apparatus (e.g. wearable sensors use for assessing balance and gait function, bioelectrical impedance analysis and dynamometer use for diagnosing sarcopenia and frailty) and clinical assessment tools to objectively measure various health outcomes; 3) conduct a quantitative empirical research including quantitative data analysis and writing research reports.
This program is research-based. It is particularly suitable for master’s students or individuals with a master’s degree. Before applying, please email the following information for preliminary review:
(1) Curriculum Vitae (CV)
(2) Research Proposal
(3) Expected start date and program duration
Research interests
- Sarcopenia
- Multidimensional Frailty
- Balance and Gait
- Disability Rehabilitation Interventions
Requirements and details
Preferred Intern Education Level
- Master’s students or individuals with a master’s degree in healthacre (medicine, nursing, rehabilitation, publica health, exercise etc.) are preferred.
Skill sets or Qualities
- Proficient English speaking and writing skills
- Interested in the following topics: geriatric syndromes, sarcopenia and frailty, balance and gait, falls and fear of falling.
Scholarship availability
International Internship Pilot Program, IIPP (NSTC) | |
International Internship Pilot Program, IIPP (NSTC) | More info |

Sung-Bau Lee, Associate Professor
Ph.D. Program in Drug Discovery and Development Industry, College of Pharmacy
Office of Global EngagementResearch Interests
- Drug discovery
- Genomic instability
- Chromatin replication
Profile: TMU Academic Hub
More information: NSTC IIPP

Yi-Chao Lee, Associate Professor
Ph.D. Program in Medical Neuroscience, College of Medical Science and Technology
Office of Global EngagementResearch Interests
Therapeutic strategies against epileptic seizures and neuropsychiatric disorders in tuberous sclerosis complex (TSC)
Profile: TMU Academic Hub
More information: NSTC IIPP

Sing-Chung Li, Associate Professor
School of Nutrition and Health Sciences, College of Nutrition
Office of Global EngagementResearch Interests
- Nutrigenomics
- Nutrition and Metabolism
- Nutrition and Food Science Technology
- Infant Nutrition
- Nutrition and Brain Health
Profile: TMU Academic Hub
More information: NSTC IIPP

Chung-Kwei Lin, Professor
School of Dental Technology, College of Oral Medicine
Office of Global EngagementResearch Interests
- Nanomaterials
- Amorphous materials
- Biomedical materials
- Surface modification
Profile: TMU Academic Hub
More information: NSTC IIPP

Hung-Yun Lin, Professor
Master Program in Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology
Office of Global EngagementResearch Interests
- Signaling induced by thyroid hormones and steroid hormones and their impact on cancer development
- The role of resveratrol and other natural products in cancer prevention Application
- Nanomedicine
Profile: TMU Academic Hub
More information: NSTC IIPP

Liang Tzung Lin, Professor
Dept. of Microbiology & Immunology, College of Medicine
Office of Global EngagementResearch Interests
- Emerging Viral Infectious Diseases (EVID)
- Oncolytic Viro-Immunotherapy (OVI)
- Molecular Virology
- Viral Entry
- Antiviral Strategies
- Vector Engineering
Profile: TMU Academic Hub
More information: NSTC IIPP

Shyh-Hsiang (Sean) Lin, Professor
School of Food Safety, College of Nutrition
Office of Global Engagement[av_textblock fold_type=” fold_height=” fold_more=’Read more’ fold_less=’Read less’ fold_text_style=” fold_btn_align=” textblock_styling_align=” textblock_styling=” textblock_styling_gap=” textblock_styling_mobile=” size=” av-desktop-font-size=” av-medium-font-size=” av-small-font-size=” av-mini-font-size=” font_color=” color=” fold_overlay_color=” fold_text_color=” fold_btn_color=’theme-color’ fold_btn_bg_color=” fold_btn_font_color=” size-btn-text=” av-desktop-font-size-btn-text=” av-medium-font-size-btn-text=” av-small-font-size-btn-t

Ya-Tin Lin, Assistant Professor
Graduate Institute of Metabolism and Obesity Sciences, College of Nutrition
Office of Global EngagementResearch Interests
- • Central regulation of metabolism
- Neural control of feeding behavior
- Pain regulation
- The release of neurotransmitters
Profile: TMU Academic Hub
More information: NSTC IIPP

Yung-Feng Lin, Associate Professor
School of Medical Laboratory Science and Biotechnology, College of Medical Science and Technology
Office of Global EngagementResearch Interests
- Neuropathologic biomarkers
- Aging & degeneration
- Cellular detoxification
Profile: TMU Academic Hub
More information: NSTC IIPP

Chao-Lien Liu, Professor
School of Medical Laboratory Science and Biotechnology, College of Medical Science and Technology
Office of Global Engagement
Yen-Nien Liu, Associate Professor
Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology
Office of Global Engagement
David J. Lundy, Associate Professor
Graduate Institute of Biomedical Materials and Tissue Engineering, College of Biomedical Engineering
Office of Global EngagementResearch Interests
We are researching new therapies using biomaterials, cells, and cell components (growth factors, cytokines, extracellular vesicles) as treatments. In particular, we are interested in combining these approaches; i.e. biomaterials to improve cell retention and activity, or methods to improve the cargo and function of extracellular vesicles.
Profile: TMU Academic Hub
More information: NSTC IIPP

Jihwan Myung, Associate Professor
Graduate Institute of Mind, Brain and Consciousness, College of Humanities and Social Sciences
Office of Global EngagementResearch Interests
- Mind Brain and Consciousness
- Physiology
- Renal Physiology & Nephrology
- Soft Matter and Biophysics-Simulation
- Neuroendocrinology
- Physiology
- Biochemistry and Molecular Biology – Medicine
- Biological Biochemistry and Molecular Biology
- Dementia
- Biological Psychiatry
- Molecular Biology
- Computational Biology
- Soft Matters and Biophysics-Experiment
Profile: TMU Academic Hub
More information: NSTC IIPP

Kunal Nepali, Associate Professor
Department of Pharmaceutical Sciences, College of Pharmacy
Office of Global Engagement[av_textblock fold_type=” fold_height=” fold_more=’Read more’ fold_less=’Read less’ fold_text_style=” fold_btn_align=” textblock_styling_align=” textblock_styling=” textblock_styling_gap=” textblock_styling_mobile=” size=” av-desktop-font-size=” av-medium-font-size=” av-small-font-size=” av-mini-font-size=” font_color=” color=” fold_overlay_color=” fold_text_color=” fold_btn_color=’theme-color’ fold_btn_bg_color=” fold_btn_font_color=” size-btn-text=” av-desktop-font-size-btn-text=” av-medium-font-size-btn-text=” av-small-font-size-btn-t

Shiow-Lin Pan, Professor
Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology
Office of Global EngagementResearch Interests
- Drug Discovery and Development
- Molecular Pharmacology
- Disease Animal Model
Profile: TMU Academic Hub
More information: NSTC IIPP

Anup Pandith, Assistant Professor
International Ph.D. Program in Biomedical Engineering, College of Biomedical Engineering
Office of Global EngagementResearch Interests
- Bioanalytical Chemistry
- Chemical Biology
- Supramolecular Chemistry
- Molecular Diagnostics
- Phototheranostics
Profile: TMU Academic Hub
More information: NSTC IIPP

Dana E. Powell, Associate Professor
Graduate Institute of Humanities in Medicine, College of Humanities and Social Sciences
Office of Global Engagement[av_textblock fold_type=” fold_height=” fold_more=’Read more’ fold_less=’Read less’ fold_text_style=” fold_btn_align=” textblock_styling_align=” textblock_styling=” textblock_styling_gap=” textblock_styling_mobile=” size=” av-desktop-font-size=” av-medium-font-size=” av-small-font-size=” av-mini-font-size=” font_color=” color=” fold_overlay_color=” fold_text_color=” fold_btn_color=’theme-color’ fold_btn_bg_color=” fold_btn_font_color=” size-btn-text=” av-desktop-font-size-btn-text=” av-medium-font-size-btn-text=” av-small-font-size-btn-t

Mattia Sanna, Assistant Professor
Master Program in Global Health and Health Security, College of Public Health
Office of Global EngagementResearch Interests
- Tobacco control
- Environmental Health
- Mental Health
- Infectious disease modelling
Profile: TMU Academic Hub
More information: NSTC IIPP

Syed Abdul Shabbir, Professor
Graduate Institute of Biomedical Informatics, College of Medical Science and Technology
Office of Global EngagementResearch Interests
- Artificial Intelligence
- Digital Health
- Social Networking in Healthcare
- Health Ageing Technologies
Profile: TMU Academic Hub
More information: NSTC IIPP

Jing-Wen Shih, Associate Professor
Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology
Office of Global EngagementResearch Interests
- RNA biology, metabolism & clinical translation
- RNA-mediated stress response signaling and network
- Adaptation of cancer cells to microenvironmental stresses
- RNA-based biomarker & therapeutics
Profile: TMU Academic Hub
More information: NSTC IIPP

Cheng-Yu, Tsai, Assistant Professor
School of Biomedical Engineering, College of Biomedical Engineering
Office of Global Engagement[av_textblock fold_type=” fold_height=” fold_more=’Read more’ fold_less=’Read less’ fold_text_style=” fold_btn_align=” textblock_styling_align=” textblock_styling=” textblock_styling_gap=” textblock_styling_mobile=” size=” av-desktop-font-size=” av-medium-font-size=” av-small-font-size=” av-mini-font-size=” font_color=” color=” fold_overlay_color=” fold_text_color=” fold_btn_color=’theme-color’ fold_btn_bg_color=” fold_btn_font_color=” size-btn-text=” av-desktop-font-size-btn-text=” av-medium-font-size-btn-text=” av-small-font-size-btn-t

Pei-Shan Tsai, Professor
School of Nursing, College of Nursing
Office of Global EngagementResearch Interests
- Psychophysiology
- Biofeedback
- Stress Management
- Biobehavior Research
- Sphygmacocardiography (Pulse Wave Analysis)
- Stress Reactivity Protocol
- Blood Pressure Biofeedback
- EMG Biofeedback
- Heart Rate Variability
- HRV Biofeedback
- Neurofeedback
- Chronic Pain
- Sleep
Profile: TMU Academic Hub
More information: NSTC IIPP

Chih-Yang Wang, Assistant Professor
Ph.D. Program for Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology
Office of Global EngagementResearch Interests
- Biochemistry
- Bioinformatics
- Pharmacology
- Cell Metabolism
- Herbal Genomics
- Traditional Chinese Medicine
Profile: TMU Academic Hub
More information: NSTC IIPP

Chang-Wei Wu, Professor
Graduate Institute of Mind Brain and Consciousness, College of Humanities and Social Science
Office of Global EngagementResearch Interests
- Cognitive neuroscience in sleep
- Functional Magnetic Resonance Imaging (fMRI)
- Medical imaging and signal processing
Profile: TMU Academic Hub
More information: NSTC IIPP

Ming-Heng Wu, Associate Professor
International Ph.D. Program for Translational Science, College of Medical Science and Technology
Office of Global EngagementResearch Interests
- Cancer glycobiology
- Antibody-drug conjugate (ADC)
- Galectin roles in inflammatory and fibrotic diseases
- Risk assessment of oral premalignant lesions
- Cell therapy for Acute lung injury
Profile: TMU Academic Hub
More information: NSTC IIPP

Kai-Chiang Yang, Professor
School of Dental Technology, College of Oral Medicine
Office of Global Engagement[av_textblock fold_type=” fold_height=” fold_more=’Read more’ fold_less=’Read less’ fold_text_style=” fold_btn_align=” textblock_styling_align=” textblock_styling=” textblock_styling_gap=” textblock_styling_mobile=” size=” av-desktop-font-size=” av-medium-font-size=” av-small-font-size=” av-mini-font-size=” font_color=” color=” fold_overlay_color=” fold_text_color=” fold_btn_color=’theme-color’ fold_btn_bg_color=” fold_btn_font_color=” size-btn-text=” av-desktop-font-size-btn-text=” av-medium-font-size-btn-text=” av-small-font-size-btn-t

Pei-Ming Yang, Associate Professor
Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology
Office of Global EngagementResearch Interests
- Polypharmacology and drug repurposing for cancer therapy
- Role of autophagy in cancer treatment
- Integrative bioinformatics
Profile: TMU Academic Hub
More information: NSTC IIPP

Suh-Ching Yang, Professor
School of Nutrition and Health Sciences, College of Nutrition
Office of Global EngagementResearch Interests
- Alcoholic liver diseases
- The evaluation of healthy food
Profile: TMU Academic Hub
More information: NSTC IIPP
MENTORS AND RESEARCH TOPICS
Alphabetically sorted by Research topic.
[av_textblock fold_type=” fold_height=” fold_more=’Read more’ fold_less=’Read less’ fold_text_style=” fold_btn_align=” textblock_styling_align=” textblock_styling=” textblock_styling_gap=” textblock_styling_mobile=” size=” av-desktop-font-size=” av-medium-font-size=” av-small-font-size=” av-mini-font-size=” font_color=” color=” fold_overlay_color=” fold_text_color=” fold_btn_color=’theme-color’ fold_btn_bg_color=” fold_btn_font_color=” size-btn-text=” av-desktop-font-size-btn-text=” av-medium-font-size-btn-text=” av-small-font-size-btn-t
ext=” av-mini-font-size-btn-text=” fold_timer=” z_index_fold=” id=” custom_class=” template_class=”
[av_one_third first
[av_textblock fold_type=” fold_height=” fold_more=’Read more’ fold_less=’Read less’ fold_text_style=” fold_btn_align=” textblock_styling_align=” textblock_styling=” textblock_styling_gap=” textblock_styling_mobile=” size=” av-desktop-font-size=” av-medium-font-size=” av-small-font-size=” av-mini-font-size=” font_color=” color=” fold_overlay_color=” fold_text_color=” fold_btn_color=’theme-color’ fold_btn_bg_color=” fold_btn_font_color=” size-btn-text=” av-desktop-font-size-btn-text=” av-medium-font-size-btn-text=” av-small-font-size-btn-t
Liang-Tzung Lin
Professor
Deptartment of Microbiology and Immunology
Program Introduction
Recent outbreaks caused by viruses, including avian influenza, Dengue, Ebola, and most notably COVID-19, has changed the way of life and instilled a new vigilance necessary towards pathogenic viruses, and the need to safeguard public health for survival and the new norms of daily life. This war on viral epidemics affects everyone, and does not discriminate between individuals and countries, and necessitates our attention to better understand viruses that affect the humans and animals alike, and the complexity involved. Simply put, keep calm, and put your mask on.
Faculty Profile
Education
Ph.D., Microbiology & Immunology
Dalhousie University, Canada
M.S., Medical Biophysics
University of Toronto, Canada
B.S., Microbiology & Immunology
McGill University, Canada
Professional Appointments
Professor, Dept. of Microbiology and Immunology
Head, Molecular Virology & Oncolytics Laboratory
Vice Dean, Office of Global Engagement
Chief, International Research Section, Office of Global Engagement
Taipei Medical University, Taiwan
Adjunct Faculty, Dept. of Microbiology & Immunology
Dalhousie University, Canada
Committee Member & Co-Investigator
Canadian Network on Hepatitis C (CanHepC), Canada
Research Interests
- Molecular Virology
- Viral Entry
- Emerging Viruses
- Antiviral Strategies
- Vector Engineering
- Oncolytic Viro-Immunotherapy
Website
[av_textblock fold_type=” fold_height=” fold_more=’Read more’ fold_less=’Read less’ fold_text_style=” fold_btn_align=” textblock_styling_align=” textblock_styling=” textblock_styling_gap=” textblock_styling_mobile=” size=” av-desktop-font-size=” av-medium-font-size=” av-small-font-size=” av-mini-font-size=” font_color=” color=” fold_overlay_color=” fold_text_color=” fold_btn_color=’theme-color’ fold_btn_bg_color=” fold_btn_font_color=” size-btn-text=” av-desktop-font-size-btn-text=” av-medium-font-size-btn-text=” av-small-font-size-btn-t
NEW ERA FOR PRECISE NUTRITION: HERBAL FOOD AND DATA ANALYSIS
[/av_textblock]Jane C-J Chao
Professor
School of Nutrition and Health Sciences
Program Introduction
Herbal food has been used as traditional remedies to cure many diseases, and some of the herbs have still been used for culinary purposes recently. Nowadays herbal food continuously becomes more demanded and popular, and is consumed as herbal food products, dietary supplements, and functional foods. In some cultures or nations, daily supplements with herbal food have been seen as remedies or alternative therapies for some diseases or believed to be beneficial to improve metabolic disturbance and imbalance. Therefore, have you ever wondered what the active components of the herbal food are? How do the active components work in the human body? What are the possible mechanisms for modulating various diseases? How much is suggested to consume or supplement with the herbal food? Does it really work? Prof. Jane’s lab is mainly interested in revealing the effects of polysaccharides from Goji berries and their combination with other potential compounds such as C-phycocyanin, capsaicin, and probiotics on gastrointestinal diseases.
The association between dietary intake and chronic diseases such as obesity, hypertension, and diabetes has also been a concern in the aspects of nutritional epidemiology, which inspires us to change point of view from specific nutrients or functional components into daily dietary patterns by using big data analysis and AI prediction model via machine learning. Let us explore and gather hands-on experiences in nutritional epidemiology, study model design, and prediction from big empirical data sets.
Through this mentorship, the mentee will have the opportunity to learn (1) the foundation of herbal food, (2) the physiological function of herbal food, (3) the mechanisms of herbal food for protecting against various diseases, and (4) the correlation between dietary patterns and chronic diseases.
Faculty Profile
Education
Ph.D., Department of Human Nutrition and Food Management
M.Sc., Department of Food Science and Nutrition
The Ohio State University, USA
BS., School of Nutrition and Health Sciences
Taipei Medical University, Taiwan
Professional Appointments
2024.02- Dean, Office of Global Engagement
2015.08- Adjunct Professor, School of Health Care Administration
2004.02- Professor, School of Nutrition and Health Sciences
Taipei Medical University, Taiwan
Research Interests
Nutrition
Herbal food
Herbal food products
Functional foods
Nutritional epidemiology
[av_textblock fold_type=” fold_height=” fold_more=’Read more’ fold_less=’Read less’ fold_text_style=” fold_btn_align=” textblock_styling_align=” textblock_styling=” textblock_styling_gap=” textblock_styling_mobile=” size=” av-desktop-font-size=” av-medium-font-size=” av-small-font-size=” av-mini-font-size=” font_color=” color=” fold_overlay_color=” fold_text_color=” fold_btn_color=’theme-color’ fold_btn_bg_color=” fold_btn_font_color=” size-btn-text=” av-desktop-font-size-btn-text=” av-medium-font-size-btn-text=” av-small-font-size-btn-t
VIRAL INFECTIOUS DISEASES & ONCOLYTIC VIRO-IMMUNOTHERAPY INTERNSHIP TRAINING PROGRAM
[/av_textblock]Liang-Tzung Lin
Professor
Deptartment of Microbiology and Immunology
Program Introduction
This training program is intended to train the individual in the areas of emerging viral infectious disease as well as the development and application of viral oncolytics. The program aims to provide the trainee with basic knowledge and hands-on experience on viruses and the associated laboratory techniques that are required for the understanding of viral pathogenesis and the use of viral oncolytics as a novel treatment against human cancers. Specifically, the trainee will undergo rigorous training in the basic techniques in cell culture, virus culture, cell transfection, cell cytotoxicity analysis, western blotting, immunofluorescence, microscopy, flow cytometry, drug screening analysis, and oncolytic viral assays. The trainee will also learn how to develop model systems for studying emerging viral infectious diseases and engineer oncolytic vectors for oncolytic virotherapy.
Faculty Profile
Education
Ph.D., Microbiology & Immunology
Dalhousie University, Canada
M.S., Medical Biophysics
University of Toronto, Canada
B.S., Microbiology & Immunology
McGill University, Canada
Professional Appointments
Professor, Dept. of Microbiology and Immunology
Head, Molecular Virology & Oncolytics Laboratory
Vice Dean, Office of Global Engagement
Chief, International Research Section, Office of Global Engagement
Taipei Medical University, Taiwan
Adjunct Faculty, Dept. of Microbiology & Immunology
Dalhousie University, Canada
Committee Member & Co-Investigator
Canadian Network on Hepatitis C (CanHepC), Canada
Research Interests
- Molecular Virology
- Viral Entry
- Emerging Viruses
- Antiviral Strategies
- Vector Engineering
- Oncolytic Viro-Immunotherapy
Website
[av_textblock fold_type=” fold_height=” fold_more=’Read more’ fold_less=’Read less’ fold_text_style=” fold_btn_align=” textblock_styling_align=” textblock_styling=” textblock_styling_gap=” textblock_styling_mobile=” size=” av-desktop-font-size=” av-medium-font-size=” av-small-font-size=” av-mini-font-size=” font_color=” color=” fold_overlay_color=” fold_text_color=” fold_btn_color=’theme-color’ fold_btn_bg_color=” fold_btn_font_color=” size-btn-text=” av-desktop-font-size-btn-text=” av-medium-font-size-btn-text=” av-small-font-size-btn-t
ext=” av-mini-font-size-btn-text=” fold_timer=” z_index_fold=” id=” custom_class=” template_class=”
[av_one_third first
Aging and Health Internship Training Program
Application of Gamified Elements to Promote Physical Activity
Biological Time Meets Psychological Time: The Role of Circadian Rhythms in Mood and Time Perception
[av_one_third first
Biomaterials for Medical Application Internship Training Program
Cancer Care, Symptom Management, Evidence-Based Health Care
Chemical Biology, Molecular Diagnostics and Phototheranostics
[av_one_third first
Clinical Data Analysis, Precision Medicine, Biotech and Healthcare Management
Comparative Analysis of Oral Microbiota and Maximum Bite Force Between Healthy and Periodontitis Subjects
Data mining, Cancer molecular mechanism, Drug repurposing
[av_one_third first
Decipher the Integrative Role of Non-Coding RNA in Cancer Progression and Its Application for Novel Drug Discovery
Development of Precision Therapeutics in Regenerative Medicine and Cell Therapy
From Molecule to Model: Dissecting m6A methylation influence on drug resistance in gastrointestinal cancer using PDO/PDOX model
[av_one_third first
GIS analysis of air pollution and other environmental risk factors on road traffic injuries
Gyn Cancer Eradication Initiative
How Storytelling Drives Intra- and Inter-Brain Information Flow
[av_one_third first
Identification of New Biomarkers for Traumatic Brain Injury
Integrating Multiple Biomarkers to Develop an Accurate Predictive Model for The Trajectory of Post-Stroke Cognitive Impairment
International Talent Development Program for Neurological Disease Drug Research
[av_one_third first
International Talent Training Program: RNA-Based Clinical Applications in Cancer Therapy
Investigating the Neurobiology of Bipolar Disorder
Microfluidic system for biosensors, organ-on-a-chip, and drug delivery
[av_one_third first
Mindfulness-based Curriculum for Sleep Disturbances (MBCSD) and its Neurophysiological Mechanisms
Neuroscience of Consciousness and Cognition
Novel Targeted Cancer Therapeutics and Personalized Medicine
[av_one_third first